Survey on the Place of Community Pharmacists in the Detection of Cannabis Use: a Student's Point of View (CANNACY)

July 5, 2017 updated by: University Hospital, Clermont-Ferrand
The objective of this survey will be to evaluate the perception by the students (except for medical students, pharmacies) of community pharmacists concerning the management of cannabis consumption. We want to see if the student population perceives the pharmacist as the public health actor of choice, and if they would more easily turn to him or to another health professional (doctor, nurse) in case they need. Discussing possible problematic consumption or for a simple search for information. It will be assessed whether the pharmacist seems to be a good candidate and an element of choice when young adults want to take an intelligence approach to cannabis consumption.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).

Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online via the following link https://redcap.chu-clermontferrand.fr/surveys/?s=JMRF9FLRJP.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Auvergne
      • Clermont-Ferrand, Auvergne, France, 63003
        • Chu Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The young and student populations are particularly affected by the use of addictive substances, including alcohol, tobacco and cannabis. Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scolarity departments. Answer to the survey will be done online.

Description

Inclusion Criteria:

- Student following a university path in the Auvergne Rhone Alpes region

Exclusion Criteria:

  • Medical student
  • Pharmacy student
  • age < 18-year
  • Other than student

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Students
Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online.
This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Role of health professionals in the prevention of cannabis addiction
Time Frame: at day 1
Students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) in the prevention of cannabis addiction
at day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Role of health professionals for the therapeutic management of cannabis addiction
Time Frame: at day 1
Assessment of students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) for the therapeutic management of cannabis addiction.
at day 1
Cannabis consumption
Time Frame: at day 1
yes/no
at day 1
Type of cannabis used
Time Frame: at day 1
marijuana/haschich
at day 1
Frequency of cannabis use
Time Frame: at day 1
at day 1
Sought effects of cannabis use
Time Frame: at day 1
Recreational / Stone / Therapeutic / Other expected effect
at day 1
Level of knowledge on cannabis
Time Frame: at day 1
Yes I know the risk / No I don't know the risk
at day 1
Consumption of cigarettes
Time Frame: at day 1
yes/no
at day 1
Consumption of e-cigarettes
Time Frame: at day 1
yes/no
at day 1
Consumption of alcohol
Time Frame: at day 1
yes/no
at day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 5, 2017

Primary Completion (ACTUAL)

June 2, 2017

Study Completion (ACTUAL)

June 2, 2017

Study Registration Dates

First Submitted

May 11, 2017

First Submitted That Met QC Criteria

May 23, 2017

First Posted (ACTUAL)

May 25, 2017

Study Record Updates

Last Update Posted (ACTUAL)

July 7, 2017

Last Update Submitted That Met QC Criteria

July 5, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CHU-333
  • 2017-A00328-45 (OTHER: 2017-A00328-45)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cannabis Use

Clinical Trials on Survey

Subscribe